Cocrystal Pharma (COCP)
(Delayed Data from NSDQ)
$2.80 USD
+0.08 (2.94%)
Updated Jun 12, 2024 04:00 PM ET
After-Market: $2.94 +0.14 (5.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/12/24 |
---|---|
Current Quarter | -0.51 |
EPS Last Quarter | -0.39 |
Last EPS Surprise | 27.78% |
ABR | 1.00 |
Earnings ESP
|
10.89% |
---|---|
Current Year | -2.02 |
Next Year | -2.04 |
EPS (TTM) | -1.74 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.51 | -0.55 | -2.02 | -2.04 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.45 | -0.50 | -2.15 | -1.64 |
High Estimate | -0.45 | -0.50 | -1.89 | -1.64 |
Low Estimate | -0.56 | -0.59 | -2.15 | -2.44 |
Year ago EPS | -0.50 | -0.41 | -1.87 | -2.02 |
Year over Year Growth Est. | -2.00% | -34.15% | -8.02% | -0.99% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 2 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.51 | -0.55 | -2.02 | -2.04 |
7 Days Ago | -0.51 | -0.55 | -2.02 | -2.04 |
30 Days Ago | -0.57 | -0.59 | -2.30 | -1.96 |
60 Days Ago | -0.57 | -0.59 | -2.18 | -1.46 |
90 Days Ago | -0.58 | -0.59 | -2.20 | -1.45 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.45 | -0.50 | -2.02 | -1.64 |
Zacks Consensus Estimate | -0.51 | -0.55 | -2.02 | -2.04 |
Earnings ESP | 10.89% | 8.26% | 0.00% | 19.61% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.39 | -0.44 | -0.41 | -0.50 | NA |
Estimate | -0.54 | -0.57 | -0.47 | -0.53 | NA |
Difference | 0.15 | 0.13 | 0.06 | 0.03 | 0.09 |
Surprise | 27.78% | 22.81% | 12.77% | 5.66% | 17.26% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more